Genetic Testing for Myocarditis

Elizabeth M. McNally; Daniel F. Selgrade

doi:10.1016/j.jchf.2022.07.003

Genetic Testing for Myocarditis

Elizabeth M. McNally^*, Daniel F. Selgrade

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Editorial › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	728-730
Number of pages	3
Journal	JACC: Heart Failure
Volume	10
Issue number	10
DOIs	https://doi.org/10.1016/j.jchf.2022.07.003
State	Published - Oct 2022

Funding

The authors have received support from the National Heart, Lung, and Blood Institute and the Leducq Foundation. Dr McNally serves as a consultant to Amgen, Avidity, AstraZeneca, Cytokinetics, Janssen, PepGen, Pfizer, Stealth Bio, Tenaya, and Invitae, which is unrelated to the content of this paper. Mr Selgrade has reported that he has no relationships relevant to the contents of this paper to disclose.

Keywords

desmoplakin
desmosome
myocarditis

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jchf.2022.07.003

Cite this

@article{d5bb2480c3e94638ba756702c5ff30e3,

title = "Genetic Testing for Myocarditis",

keywords = "desmoplakin, desmosome, myocarditis",

author = "McNally, {Elizabeth M.} and Selgrade, {Daniel F.}",

note = "Funding Information: The authors have received support from the National Heart, Lung, and Blood Institute and the Leducq Foundation. Dr McNally serves as a consultant to Amgen, Avidity, AstraZeneca, Cytokinetics, Janssen, PepGen, Pfizer, Stealth Bio, Tenaya, and Invitae, which is unrelated to the content of this paper. Mr Selgrade has reported that he has no relationships relevant to the contents of this paper to disclose.",

year = "2022",

month = oct,

doi = "10.1016/j.jchf.2022.07.003",

language = "English (US)",

volume = "10",

pages = "728--730",

journal = "JACC: Heart Failure",

issn = "2213-1779",

publisher = "Elsevier BV",

number = "10",

}

TY - JOUR

T1 - Genetic Testing for Myocarditis

AU - McNally, Elizabeth M.

AU - Selgrade, Daniel F.

N1 - Funding Information: The authors have received support from the National Heart, Lung, and Blood Institute and the Leducq Foundation. Dr McNally serves as a consultant to Amgen, Avidity, AstraZeneca, Cytokinetics, Janssen, PepGen, Pfizer, Stealth Bio, Tenaya, and Invitae, which is unrelated to the content of this paper. Mr Selgrade has reported that he has no relationships relevant to the contents of this paper to disclose.

PY - 2022/10

Y1 - 2022/10

KW - desmoplakin

KW - desmosome

KW - myocarditis

UR - http://www.scopus.com/inward/record.url?scp=85138022285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85138022285&partnerID=8YFLogxK

U2 - 10.1016/j.jchf.2022.07.003

DO - 10.1016/j.jchf.2022.07.003

M3 - Editorial

C2 - 36175057

AN - SCOPUS:85138022285

SN - 2213-1779

VL - 10

SP - 728

EP - 730

JO - JACC: Heart Failure

JF - JACC: Heart Failure

IS - 10

ER -

Genetic Testing for Myocarditis

Funding

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this